Ligand validation:3W13

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3W13 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3W13_NAG_E_406	38%	44%	0.225	0.928	0.5	1.68	-	3	1	0	100%	0.9333
3W13_NAG_E_401	9%	23%	0.331	0.83	0.8	2.52	-	3	1	0	100%	0.9333
7KD6_NAG_E_401	74%	70%	0.138	0.97	0.33	0.79	-	1	0	0	100%	0.9333
3W12_NAG_E_406	43%	53%	0.211	0.937	0.44	1.38	-	3	0	0	100%	0.9333
6VEQ_NAG_E_507	36%	79%	0.192	0.884	0.28	0.57	-	-	2	0	100%	0.9333
4OGA_NAG_E_507	31%	56%	0.214	0.883	0.37	1.29	-	2	0	0	100%	0.9333
4XSS_NAG_E_407	30%	50%	0.25	0.917	0.31	1.6	-	3	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.